
|Articles|July 7, 2003
Drug errors associated with opium tincture and paregoric
FDA will require new labeling for Opium Tincture and Paregoric, which have been associated with several drug errors.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
ASHP Adopts New Policies Around Misinformation and Vaccine Access Gaps
5




























